SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far
- PMID: 32245083
- PMCID: PMC7157541
- DOI: 10.3390/pathogens9030231
SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far
Abstract
In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes.
Keywords: COVID-19; Coronavirus; SARS; SARS-CoV-2; Wuhan; pandemic.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
COVID-19 in Human, Animal, and Environment: A Review.Front Vet Sci. 2020 Sep 4;7:578. doi: 10.3389/fvets.2020.00578. eCollection 2020. Front Vet Sci. 2020. PMID: 33102545 Free PMC article. Review.
-
Clinical Spectrum of COVID-19 Cases and their Correlation with S.LDH Levels- An Observational Study from Southeast Rajasthan.J Assoc Physicians India. 2021 Sep;69(9):11-12. J Assoc Physicians India. 2021. PMID: 34585882
-
Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).Clin Exp Pediatr. 2020 Apr;63(4):119-124. doi: 10.3345/cep.2020.00493. Epub 2020 Apr 2. Clin Exp Pediatr. 2020. PMID: 32252141 Free PMC article.
-
Comprehensive overview of COVID-19 based on current evidence.Dermatol Ther. 2020 Sep;33(5):e13525. doi: 10.1111/dth.13525. Epub 2020 May 22. Dermatol Ther. 2020. PMID: 32378801 Free PMC article. Review.
-
The novel zoonotic COVID-19 pandemic: An expected global health concern.J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671. J Infect Dev Ctries. 2020. PMID: 32235085
Cited by
-
Can pharmaceutical drugs used to treat Covid-19 infection leads to human health risk? A hypothetical study to identify potential risk.Sci Total Environ. 2021 Jul 15;778:146303. doi: 10.1016/j.scitotenv.2021.146303. Epub 2021 Mar 9. Sci Total Environ. 2021. PMID: 34030377 Free PMC article.
-
Reducing SARS-CoV-2 pathological protein activity with small molecules.J Pharm Anal. 2021 Aug;11(4):383-397. doi: 10.1016/j.jpha.2021.03.012. Epub 2021 Apr 5. J Pharm Anal. 2021. PMID: 33842018 Free PMC article. Review.
-
Evaluation of Multiplex Rapid Antigen Tests for the Simultaneous Detection of SARS-CoV-2 and Influenza A/B Viruses.Biomedicines. 2023 Dec 9;11(12):3267. doi: 10.3390/biomedicines11123267. Biomedicines. 2023. PMID: 38137488 Free PMC article.
-
FnCas9-based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV-2 variants on a paper strip.Elife. 2021 Jun 9;10:e67130. doi: 10.7554/eLife.67130. Elife. 2021. PMID: 34106048 Free PMC article.
-
Micronutrients as immunomodulatory tools for COVID-19 management.Clin Immunol. 2020 Nov;220:108545. doi: 10.1016/j.clim.2020.108545. Epub 2020 Jul 22. Clin Immunol. 2020. PMID: 32710937 Free PMC article. Review.
References
-
- Coronaviridae—Positive Sense RNA Viruses—Positive Sense RNA Viruses. [(accessed on 15 March 2020)];2011 Available online: https://talk.ictvonline.org/ictv-reports/ictv_9th_report/positive-sense-....
-
- Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., Haagmans B.L., Lauber C., Leontovich A.M., Neuman B.W., et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses—A statement of the Coronavirus Study Group. Microbiology. 2020 doi: 10.1101/2020.02.07.937862. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous